+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Genmab AS - logo

Genmab is a leading biotechnology company that focuses on developing innovative antibody products. Arzerra is the company’s first marketed antibody and is approved to treat chronic lymphocytic leukemia (CLL) patients in all major markets. Another product, Darzalex, has been approved in the United States for the treatment of patients with multiple myeloma. Genmab was founded in Copenhagen, Denmark in 1999 and employs around 200 people.

From
Global Cancer Monoclonal Antibodies Market & Pipeline Insight - Product Thumbnail Image

Global Cancer Monoclonal Antibodies Market & Pipeline Insight

  • Drug Pipelines
  • October 2014
  • 1400 Pages
From
From
From
From
From
From
From
From
Global Monoclonal Antibodies Pipeline Insight 2015 - Product Thumbnail Image

Global Monoclonal Antibodies Pipeline Insight 2015

  • Drug Pipelines
  • March 2015
  • 1600 Pages
From
From
Thyroid Cancer - Pipeline Review, H1 2020 - Product Thumbnail Image

Thyroid Cancer - Pipeline Review, H1 2020

  • Drug Pipelines
  • March 2020
  • 885 Pages
From
From
From
From
Loading Indicator
adroll